The Protein Expression and Proteomics (PEP) Core received supplemental funding for one year startingJune 1, 2006, to provide an unmet need for our community of investigators. The Protein Expression portionof the proposed pilot Core, under the direction of Dr. John Elder, will provide the appropriate vectors andcell lines needed to facilitate expression cloning of investigator-targeted proteins. The Proteomics portion ofthe core, under the direction of Dr. Bruce Torbett, will provide protein analysis services for CFARinvestigators. These services include protein extraction from viruses, cells, and tissues; protein resolutionand quantification using 1- and 2-dimensional (D) electrophoresis and imaging systems; proteinidentification using mass spectroscopy; and analyses of proteins using Luminex xMAP multiplexdetection technology. The unique aspect of the PEP Core is the focus on providing services to investigatorsrequiring expression of proteins from HIV-1 and other viral genes and protein analysis of HIV-1 and othervirally infected samples.The Protein Expression portion of the Core will provide the appropriate vectors and cell lines needed tofacilitate expression cloning of investigator-targeted proteins, using bacterial, insect cell, or mammalian cellvector systems, as deemed appropriate for the particular application. The Elder laboratory has compiled anextensive panel of vectors for each expression system and has extensive experience in protein expressionand purification for ligand binding studies, enzymology, and crystallographic analyses. The laboratory isequipped with incubators required to grow cells at the required temperatures and also centrifuges, FPLC,and HPLC systems to aid in protein purification where necessary. The Core will aid the investigator invector selection and amplification and cloning of targeted genes. In addition, the Core will help investigatorsin optimizing protein expression and selection of purification schemes most appropriate for eachapplication.The Proteomics portion of the Core will provide all facets of protein resolution from visualization toidentification. CFAR members will have access to the NCI-funded Proteomics Core housed within theDepartmental of Molecular and Experimental Medicine at The Scripps Research Institute. Currently theProteomics Core has available 1- and 2-D gel electrophoresis protein separation instrumentation, IEFZoom fractionators for solution phase IEF, a state-of-the-art 2D Proteomic Imaging System with a Bio-RadVersaDoc 1000 imager and imaging software. All imaging software can be utilized free of charge onresident computers housed within the Core. Technical advice is available from the Core technicians, andwhen needed, Core technicians provide demonstrations and seminars on analysis and imaging software. Inaddition, Core technicians will provide advice to investigators for optimizing protein extraction proceduresand selection of purification schemes most appropriate for each application.The Protein Expression and Proteomics Core will provide informational seminars/sessions on the Coreservices each year and 'new technology' seminars/sessions throughout the funding period.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI036214-15
Application #
7635793
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2008-06-01
Project End
2012-05-31
Budget Start
2008-06-01
Budget End
2009-05-31
Support Year
15
Fiscal Year
2008
Total Cost
$170,294
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Blumenthal, Jill; Jain, Sonia; Mulvihill, Evan et al. (2018) Perceived versus calculated HIV risk: Implications for Pre-exposure prophylaxis uptake in a randomized trial of men who have sex with men. J Acquir Immune Defic Syndr :
Naticchia, Matthew R; Laubach, Logan K; Tota, Ember M et al. (2018) Embryonic Stem Cell Engineering with a Glycomimetic FGF2/BMP4 Co-Receptor Drives Mesodermal Differentiation in a Three-Dimensional Culture. ACS Chem Biol 13:2880-2887
Wagner, Karla D; Syvertsen, Jennifer L; Verdugo, Silvia R et al. (2018) A mixed methods study of the social support networks of female sex workers and their primary noncommercial male partners in Tijuana, Mexico. J Mix Methods Res 12:437-457
Bastos, Francisco I; Bastos, Leonardo Soares; Coutinho, Carolina et al. (2018) HIV, HCV, HBV, and syphilis among transgender women from Brazil: Assessing different methods to adjust infection rates of a hard-to-reach, sparse population. Medicine (Baltimore) 97:S16-S24
Kardava, Lela; Sohn, Haewon; Youn, Christine et al. (2018) IgG3 regulates tissue-like memory B cells in HIV-infected individuals. Nat Immunol 19:1001-1012
Namazi, Golnaz; Fajnzylber, Jesse M; Aga, Evgenia et al. (2018) The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies. J Infect Dis 218:1954-1963
Lada, Steven M; Huang, Karissa; VanBelzen, D Jake et al. (2018) Quantitation of Integrated HIV Provirus by Pulsed-Field Gel Electrophoresis and Droplet Digital PCR. J Clin Microbiol 56:
Cepeda, Javier A; Eritsyan, Ksenia; Vickerman, Peter et al. (2018) Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study. Lancet HIV 5:e578-e587
Skaathun, Britt; Voisin, Dexter R; Cornwell, Benjamin et al. (2018) A Longitudinal Examination of Factors Associated with Network Bridging Among YMSM: Implications for HIV Prevention. AIDS Behav :
Stone, Jack; Fraser, Hannah; Lim, Aaron G et al. (2018) Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Infect Dis 18:1397-1409

Showing the most recent 10 out of 921 publications